Research Topics
Genomes and Genes | N FerraraSummaryAffiliation: Genentech Inc Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Angiogenesis as a therapeutic targetNapoleone Ferrara
Genentech, 1 DNA Way, South San Francisco, California 94080, USA
Nature 438:967-74. 2005..Therapeutic angiogenesis (promoting new vessel growth to treat ischaemic disorders) is an exciting frontier of cardiovascular medicine, but further understanding of the mechanisms of vascular morphogenesis is needed first...
Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cellsFarbod Shojaei
Genentech, Inc, South San Francisco, California 94080, USA
Cancer Res 68:5501-4. 2008..Thus, G-CSF may promote tumor angiogenesis through a Bv8-dependent pathway that bypasses VEGF and renders tumors refractory to anti-VEGF therapy...
Role of vascular endothelial growth factor in regulation of physiological angiogenesisN Ferrara
Department of Molecular Oncology, Genentech, Inc, South San Francisco, CA 94080, USA
Am J Physiol Cell Physiol 280:C1358-66. 2001..Substantial evidence also implicates VEGF as an angiogenic mediator in tumors and intraocular neovascular syndromes, and numerous clinical trials are presently testing the hypothesis that inhibition of VEGF may have therapeutic value...
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNapoleone Ferrara
Department of Molecular Oncology, Genentech, Inc, 1 DNA Way, South San Francisco, California 94080, USA
Nat Rev Drug Discov 3:391-400. 2004
Role of vascular endothelial growth factor in the regulation of angiogenesisN Ferrara
Department of Cardiovascular Research, Genentech, Inc, South San Francisco, California 94080, USA
Kidney Int 56:794-814. 1999..Currently, both therapeutic angiogenesis using recombinant VEGF or VEGF gene transfer and inhibition of VEGF-mediated pathological angiogenesis are being pursued clinically...
Molecular and biological properties of vascular endothelial growth factorN Ferrara
Department of Cardiovascular Research, Genentech Inc, South San Francisco, CA 94080, USA
J Mol Med (Berl) 77:527-43. 1999..Currently, both therapeutic angiogenesis using recombinant VEGF or VEGF gene transfer and inhibition of VEGF-mediated pathological angiogenesis are being pursued...
EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factorsNapoleone Ferrara
Department of Molecular Oncology, Genentech Inc, South San Francisco, CA 94080, USA
Biochim Biophys Acta 1654:69-78. 2004..Bv8 expression is mainly restricted to the testis. The identification of these tissue-selective angiogenic factors raises the possibility that other secreted molecules with selectivity for the endothelium of other organs exist...
Clinical applications of angiogenic growth factors and their inhibitorsN Ferrara
Department of Molecular Oncology Genentech DNA Way South San Francisco, California 94080, USA
Nat Med 5:1359-64. 1999..These concepts are being tested now in clinical trials...
The biology of VEGF and its receptorsNapoleone Ferrara
Department of Molecular Oncology, Genentech, Inc, 1 DNA Way, South San Francisco, California 94080, USA
Nat Med 9:669-76. 2003..VEGF inhibition is also being tested as a strategy for the prevention of angiogenesis, vascular leakage and visual loss in age-related macular degeneration...
Endocrine gland vascular endothelial growth factor (EG-VEGF) and the hypothesis of tissue-specific regulation of angiogenesisNapoleone Ferrara
Department of Molecular Oncology, Genentech Inc, South San Francisco, CA 94080, USA
Endocr Res 28:763-4. 2002
VEGF: an update on biological and therapeutic aspectsN Ferrara
Department of Molecular Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Curr Opin Biotechnol 11:617-24. 2000..Substantial evidence also implicates VEGF in tumors and intraocular neovascular syndromes. Currently, several clinical trials are ongoing to test the hypothesis that the inhibition of VEGF activity may be beneficial for these conditions...
VEGF and the quest for tumour angiogenesis factorsNapoleone Ferrara
Department of Molecular Oncology, Genentech, Inc, 1 DNA Way, South San Francisco, California 94080, USA
Nat Rev Cancer 2:795-803. 2002..How did this field begin, and how have we arrived at our present understanding of the role of VEGF in tumour progression...
Vascular endothelial growth factor: basic science and clinical progressNapoleone Ferrara
Department of Molecular Oncology, Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Endocr Rev 25:581-611. 2004..Furthermore, VEGF is implicated in intraocular neovascularization associated with diabetic retinopathy and age-related macular degeneration...
Vascular endothelial growth factor as a target for anticancer therapyNapoleone Ferrara
Genentech, Inc, South San Francisco, California 94080, USA
Oncologist 9:2-10. 2004..Of these, bevacizumab, a humanized monoclonal antibody directed at VEGF, is the most advanced in clinical development and has shown promising results in clinical trials...
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyNapoleone Ferrara
Department of Molecular Oncology, Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Biochem Biophys Res Commun 333:328-35. 2005..Furthermore, VEGF is implicated in intraocular neovascularization associated with diabetic retinopathy and age-related macular degeneration...
Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesisNapoleone Ferrara
Genentech, Inc, 1 DNA Way, South San Francisco, California, USA
Curr Opin Hematol 17:219-24. 2010..This review describes recent findings on the role of myeloid cells in refractoriness or/and acquired resistance to such therapies...
Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor actionNapoleone Ferrara
Genentech, Inc, South San Francisco, CA 94080, USA
Mol Biol Cell 21:687-90. 2010..This retrospective article examines the early studies and also emphasizes the subsequent progress in our understanding of these processes in health and disease...
VEGF-A: a critical regulator of blood vessel growthNapoleone Ferrara
Genentech, Inc, San Francisco, CA 94080, USA
Eur Cytokine Netw 20:158-63. 2009..This article examines the molecular and biological characteristics of VEGF and also discusses preclinical and clinical studies with VEGF inhibitors and the lessons learned from these studies...
Pathways mediating VEGF-independent tumor angiogenesisNapoleone Ferrara
Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Cytokine Growth Factor Rev 21:21-6. 2010..The present review examines the role of tumor- as well as stromal cell-derived pathways involved in tumor growth and in refractoriness to anti-VEGF therapies...
The role of vascular endothelial growth factor in angiogenesisN Ferrara
Department of Molecular Oncology, Genentech, Inc, South San Francisco, Calif 94080, USA
Acta Haematol 106:148-56. 2001..Substantial evidence also implicates VEGF in tumors and intraocular neovascular syndromes. Currently, several clinical trials are ongoing to test the hypothesis that inhibition of VEGF activity may be beneficial for these conditions...
Vascular endothelial growth factorNapoleone Ferrara
Genentech Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Arterioscler Thromb Vasc Biol 29:789-91. 2009..This brief review provides a historic account of the challenges associated with the discovery of VEGF and the early steps in elucidating the role of this molecule in the regulation of angiogenesis...
Targeting VEGF-A to treat cancer and age-related macular degenerationNapoleone Ferrara
Genentech, Inc, South San Francisco, California 94080, USA
Annu Rev Med 58:491-504. 2007..S. Food and Drug Administration for the treatment of cancer and the neovascular form of age-related macular degeneration. This review summarizes the basic biology of VEGF-A and illustrates the clinical progress in targeting this molecule...
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degenerationNapoleone Ferrara
Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Retina 26:859-70. 2006..Among these, ranibizumab is a high affinity recombinant Fab that neutralizes all isoforms of VEGF-A. The article briefly reviews the biology of VEGF and then focuses on the path that led to clinical development of ranibizumab...
The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potencyB A Keyt
Department of Cardiovascular Research, Genentech, Inc, South San Francisco, California 94080, USA
J Biol Chem 271:7788-95. 1996..The present findings indicate that removal of the carboxyl-terminal domain, whether it is due to alternative splicing of mRNA or to proteolysis, is associated with a significant loss in bioactivity...
VEGF is required for growth and survival in neonatal miceH P Gerber
Departments of Cardiovascular Research and Pathology, Genentech, Inc, South San Francisco, CA 94080, USA
Development 126:1149-59. 1999..Thus, VEGF is essential for growth and survival in early postnatal life. However, in the fully developed animal, VEGF is likely to be involved primarily in active angiogenesis processes such as corpus luteum development...
Identification of an angiogenic mitogen selective for endocrine gland endotheliumJ LeCouter
Department of Molecular Oncology, Genentech Inc, South San Francisco, CA 94080, USA
Nature 412:877-84. 2001..EG-VEGF is an example of a class of highly specific mitogens that act to regulate proliferation and differentiation of the vascular endothelium in a tissue-specific manner...
Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDRJ E Park
Genentech, Inc, South San Francisco, California 94080
J Biol Chem 269:25646-54. 1994..Purified PIGF isoforms had little or no direct mitogenic or permeability-enhancing activity. However, they were able to significantly potentiate the action of low concentrations of VEGF in vitro and, more strikingly, in vivo...
Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutantsH Gille
Department of Molecular Oncology, Genentech, Inc, South San Francisco, California 94080, USA
J Biol Chem 276:3222-30. 2001..We also demonstrate that KDR, but not Flt-1, stimulation is responsible for the induction of vascular permeability by VEGF...
Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesisB A Keyt
Department of Cardiovascular Research, Genentech, Inc, South San Francisco, California 94080, USA
J Biol Chem 271:5638-46. 1996..Furthermore, this mutational analysis implicates KDR, but not FLT-1, in VEGF induction of endothelial cell proliferation...
Vascular endothelial growth factor is essential for corpus luteum angiogenesisN Ferrara
Department of Cardiovascular Research, Genentech Inc, South San Francisco, California 94080, USA
Nat Med 4:336-40. 1998..Furthermore, they have implications for the control of fertility and the treatment of ovarian disorders characterized by hypervascularity and hyperplasia...
Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administrationJ Mordenti
Department of Experimental Therapeutics, Genentech, Inc, Souty San Francisco, California 94080, USA
Toxicol Pathol 27:536-44. 1999..The differences in pharmacokinetics and tissue distribution that are noted between the full-length and Fab antibodies in this study identify potential therapeutic approaches that may be exploited in specific disease conditions...
Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stabilityT Davis-Smyth
Departments of Cardiovascular Research, Genentech, Inc, South San Francisco, California 94080, USA
J Biol Chem 273:3216-22. 1998..In addition, some residues in domain 3 contribute to binding (Asp231) or provide for additional discrimination between ligands (Arg280-Asp283)...
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneN Ferrara
Department of Cardiovascular Research, Genentech Inc, South San Francisco, California 94080, USA
Nature 380:439-42. 1996..Angiogenesis and blood-island formation were impaired, resulting in several developmental anomalies. Furthermore, VEGF-null embryonic stem cells exhibit a dramatically reduced ability to form tumours in nude mice...
A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migrationH Gille
Department of Molecular Oncology, Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, USA
EMBO J 19:4064-73. 2000..These results define a novel functional domain that serves to repress Flt-1 activity in endothelial cells...
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activationH P Gerber
Department of Cardiovascular Research, Genentech, Inc, South San Francisco, California 94080, USA
J Biol Chem 273:30336-43. 1998..Inhibition of apoptosis may represent a major aspect of the regulatory activity of VEGF on the vascular endothelium...
Dobutamine stress cine-MRI of cardiac function in the hearts of adult cardiomyocyte-specific VEGF knockout miceS P Williams
Genentech, Inc, 1 DNA Way 72A, South San Francisco, CA 94080, USA
J Magn Reson Imaging 14:374-82. 2001..A prolonged high-dose dobutamine challenge was monitored by MRI. A maximal response was sustained for 90 minutes, suggesting that it did not depend on endogenous glycogen stores...
VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brainN van Bruggen
Department of Neuroscience, Genentech Inc, South San Francisco, California 94080, USA
J Clin Invest 104:1613-20. 1999..These results demonstrate that antagonism of VEGF reduces ischemia/reperfusion-related brain edema and injury, implicating VEGF in the pathogenesis of stroke and related disorders...
Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humansJ Mordenti
Experimental Therapeutics, Genentech, Inc, South San Francisco, California 94080, USA
Toxicol Pathol 27:14-21. 1999....
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cellsY L Hu
Center for Reproductive Sciences, University of California, San Francisco, USA
J Natl Cancer Inst 93:762-8. 2001..However, this LPA response is not evident in normal ovarian surface epithelial cells. Our data suggest that Edg4, but not Edg2, plays a role in LPA stimulation of ovarian tumor growth...
Vascular endothelial growth factor is a secreted angiogenic mitogenD W Leung
Department of Molecular Biology, Genetech, South San Francisco, CA 94080
Science 246:1306-9. 1989..Human 293 cells transfected with an expression vector containing a bovine or human VEGF cDNA insert secrete an endothelial cell mitogen that behaves like native VEGF...
Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxiaH P Gerber
Department of Cardiovascular Research, Genentech, Inc, South San Francisco, California 94080, USA
J Biol Chem 272:23659-67. 1997..These findings indicate that, unlike the KDR/Flk-1 gene, the Flt-1 receptor gene is directly up-regulated by hypoxia via a hypoxia-inducible enhancer element located at positions -976 to -937 of the Flt-1 promoter...
The role of EG-VEGF in the regulation of angiogenesis in endocrine glandsJ LeCouter
Department of Molecular Oncology, Genentech, Inc, South San Francisco, California 94080, USA
Cold Spring Harb Symp Quant Biol 67:217-21. 2002
Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivoX Xin
Department of Cardiovascular Research, Genentech Inc, South San Francisco, CA 94080, USA
Am J Pathol 158:1111-20. 2001..We suggest that combination therapy using HGF and VEGF co-administration may provide a more effective strategy to achieve therapeutic angiogenesis...
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNAK A Houck
Department of Molecular Biology, Genetech, Inc, South San Francisco, California 94080
Mol Endocrinol 5:1806-14. 1991..Thus, alternative splicing of VEGF RNA can produce four polypeptides with strikingly different secretion patterns, which suggests multiple physiological roles for this family of proteins...
Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinomaR S Warren
Department of Surgery, University of California School of Medicine, San Francisco, California 94143, USA
J Biol Chem 271:29483-8. 1996..Thus, in addition to its direct, growth stimulatory effect on transformed cells, IGF-I induces the expression of VEGF which can promote the progression of cancer by regulating the development of new blood vessels...
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsN Ferrara
Department of Pharmacological Sciences, Genentech Inc, South San Francisco, CA 94080
Biochem Biophys Res Commun 161:851-8. 1989..Microsequencing reveals a unique N-terminal amino acid sequence. On the basis of its apparent target cell selectivity, we propose to name this factor vascular endothelial growth factor (VEGF)...
Angiogenesis and bone growthH P Gerber
Department of Molecular Oncology, Genentech, Inc, South San Francisco, CA 94080, USA
Trends Cardiovasc Med 10:223-8. 2000..The fundamental importance of chondrocytes in the growth, development and repair of the skeleton has led to intense investigation of the mechanisms that regulate chondrocyte maturation and apoptosis...
Developmental and pathological angiogenesisAlicia S Chung
Genentech, Inc, South San Francisco, California 94080, USA
Annu Rev Cell Dev Biol 27:563-84. 2011..We also discuss current knowledge of physiological angiogenic processes as well as their disruptions in pathological processes, particularly tumorigenesis...
Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual functionAlexander G Marneros
Department of Cell Biology, Harvard Medical School, 188 Longwood Ave, Boston, MA 02115, USA
Am J Pathol 167:1451-9. 2005..Thus, hypoxia-inducible factor-1alpha-independent expression of VEGF is essential for choroid development...
Angiogenic inhibitors: a new therapeutic strategy in oncologyGiampietro Gasparini
Division of Medical Oncology, San Filippo Neri Hospital, Via G Martinotti, 20 00135 Rome, Italy
Nat Clin Pract Oncol 2:562-77. 2005....
Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGFWei-Ching Liang
Department of Protein Engineering, Genentech Inc, South San Francisco, CA 94080, USA
J Biol Chem 281:951-61. 2006..Thus, the functional contribution of stromal VEGF varies greatly among tumors, and systemic blockade of both tumor and stroma-derived VEGF is sufficient for inhibiting the growth of tumor xenografts...
VEGF as a therapeutic target in cancerNapoleone Ferrara
Genentech Inc, San Francisco, Calif 94080, USA
Oncology 69:11-6. 2005..The best-studied and most advanced approach to VEGF inhibition is the humanized monoclonal antibody bevacizumab (Avastin), which is the only anti-angiogenic agent approved for treatment of cancer...
Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinomaMax L Tejada
Department of Molecular Oncology, Pathology, Genentech, Inc, South San Francisco, California 94080, USA
Clin Cancer Res 12:2676-88. 2006..We propose that therapies targeting this stromal cell type may be effective in treating certain types of solid tumors...
Imaging tumor angiogenesisKristy Red-Horse
Genentech Inc, South San Francisco, California 94080, USA
J Clin Invest 116:2585-7. 2006....
Corneal avascularity is due to soluble VEGF receptor-1Balamurali K Ambati
Department of Ophthalmology, Medical College of Georgia and Augusta Veterans Affairs Medical Center, Augusta, Georgia 30907, USA
Nature 443:993-7. 2006....
Antiangiogenesis to treat cancer and intraocular neovascular disordersFarbod Shojaei
Genentech Inc, South San Francisco, CA 94080, USA
Lab Invest 87:227-30. 2007..This brief review focuses on the progress in targeting one of the major regulators of angiogenesis, VEGF-A, and also discusses potential cellular and molecular mechanisms underlying resistance to antiangiogenic treatments...
Napoleone Ferrara and the saga of vascular endothelial growth factorDomenico Ribatti
Department of Human Anatomy and Histology, University of Bari Medical School, Bari, Italy
Endothelium 15:1-8. 2008....
VEGF inhibition and renal thrombotic microangiopathyVera Eremina
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
N Engl J Med 358:1129-36. 2008..These observations provide evidence that glomerular injury in patients who are treated with bevacizumab is probably due to direct targeting of VEGF by antiangiogenic therapy...
Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changesClaudio Campa
Genentech, Inc, South San Francisco, California, USA
Invest Ophthalmol Vis Sci 49:1178-83. 2008..The purpose of this study was to evaluate different methods of detecting and quantifying experimentally induced choroidal neovascularization (CNV) and vascular changes induced on CNV by an anti-VEGF-A monoclonal antibody...
Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progressionFarbod Shojaei
Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Proc Natl Acad Sci U S A 105:2640-5. 2008..In summary, our studies verify a role for Bv8 in the mobilization and recruitment of myeloid cells and in the induction of tumor angiogenesis in the early stages of neoplastic progression...
Interaction between bevacizumab and murine VEGF-A: a reassessmentLanlan Yu
Genentech Inc, South San Francisco, CA 94080, USA
Invest Ophthalmol Vis Sci 49:522-7. 2008..However, a recent study reported that bevacizumab is a potent inhibitor of hemangiogenesis and lymphangiogenesis in murine models. The authors sought to reassess the interaction between bevacizumab and mVEGF-A...
Autocrine VEGF signaling is required for vascular homeostasisSunyoung Lee
Department of Molecular, Cellular and Developmental Biology, Jonsson Comprehensive Cancer Center and Molecular Biology Institute, UCLA, Los Angeles, CA 90095, USA
Cell 130:691-703. 2007..These results reveal a cell-autonomous VEGF signaling pathway that holds significance for vascular homeostasis but is dispensable for the angiogenic cascade...
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cellsFarbod Shojaei
Genentech, Inc, 1 DNA Way, S San Francisco, California 94080, USA
Nat Biotechnol 25:911-20. 2007..These findings indicate that, in our models, refractoriness to anti-VEGF treatment is determined by the ability of tumors to prime and recruit CD11b+Gr1+ cells...
Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesisHiroaki Yamamoto
Department of Medicine and Lung Biology Center, University of California, San Francisco, CA 94143, USA
Dev Biol 308:44-53. 2007....
Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min miceNina Korsisaari
Genentech, Inc, South San Francisco, CA 94080, USA
Proc Natl Acad Sci U S A 104:10625-30. 2007..Therefore, VEGF-A inhibition may be a previously uncharacterized strategy for the prevention of the angiogenic switch and growth in intestinal adenomas...
Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodiesHans Peter Gerber
Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Proc Natl Acad Sci U S A 104:3478-83. 2007..However, higher-affinity antibodies were more likely to result in glomerulosclerosis during long-term treatment...
Bv8 regulates myeloid-cell-dependent tumour angiogenesisFarbod Shojaei
Genentech Inc, 1 DNA Way, South San Francisco, California 94080, USA
Nature 450:825-31. 2007..Thus, Bv8 modulates mobilization of CD11b+Gr1+ cells from the bone marrow during tumour development and also promotes angiogenesis locally...
Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in miceAjay K Malik
Department of Pathology, Genentech, South San Francisco, CA 94080, USA
Blood 107:550-7. 2006..The absence of compensatory VEGFR-1 signaling by VEGF-B and PlGF may have important implications for the development of anticancer strategies targeting the VEGF ligand/receptor system...
HIF-1alpha is essential for myeloid cell-mediated inflammationThorsten Cramer
Molecular Biology Section, Division of Biological Sciences, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA
Cell 112:645-57. 2003..This role for HIF-1alpha demonstrates its direct regulation of survival and function in the inflammatory microenvironment...
The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cellsJennifer LeCouter
Department of Molecular Oncology, Genentech, Inc, South San Francisco, CA 94080, USA
Proc Natl Acad Sci U S A 100:2685-90. 2003..The testis exhibits relatively high turnover of endothelial cells. Therefore, Bv8 and EG-VEGF, along with other factors such as VEGF-A, may maintain the integrity and also regulate proliferation of the blood vessels in the testis...
Angiogenesis-independent endothelial protection of liver: role of VEGFR-1Jennifer LeCouter
Departments of Molecular Oncology, Protein Engineering, and Pathology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Science 299:890-3. 2003..Thus, VEGFR-1 agonists may have therapeutic potential for preservation of organ function in certain liver disorders...
The role of VEGF in normal and neoplastic hematopoiesisHans Peter Gerber
Department of Molecular Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080, USA
J Mol Med (Berl) 81:20-31. 2003....
Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implicationsNapoleone Ferrara
Genentech, Inc, 1 DNA Way MS-40, South San Francisco, CA 94080, USA
Semin Oncol 29:10-4. 2002..Clinical efficacy of antiangiogenic therapy with bevacizumab is being evaluated in several phase 3 trials in various types of cancer, as well as in patients with age-related macular degeneration...
Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancerLimin Hu
Center for Reproductive Sciences, University of California at San Francisco 94143, USA
Am J Pathol 161:1917-24. 2002..Thus, combination therapy with inhibitors of VEGF plus paclitaxel may be an effective way to markedly reduce tumor growth and ascites in ovarian carcinoma...
Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesisJennifer LeCouter
Department of Molecular Oncology, Genentech, Inc, South San Francisco, California, USA
Nat Med 8:913-7. 2002..Endocrine gland-derived VEGF represents the first example of a tissue-specific angiogenic factor, likely to be followed by others...
Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnoverJohn Street
Department of Academic Surgery, National University of Ireland, University College Cork, Cork, Ireland
Proc Natl Acad Sci U S A 99:9656-61. 2002....
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanismHans Peter Gerber
Department of Molecular Oncology, Genentech, Inc, 1 DNA Way, South San Francisco, California 94080, USA
Nature 417:954-8. 2002..Not only ligands selective for VEGF and VEGFR-2 but also VEGFR-1 agonists rescued survival and repopulation of VEGF-deficient HSCs, revealing a function for VEGFR-1 signalling during haematopoiesis...
VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesisMasahiro Inoue
Department of Biochemistry and Biophysics, Diabetes and Comprehensive Cancer Centers, University of California at San Francisco, San Francisco, CA 94143, USA
Cancer Cell 1:193-202. 2002..Thus, VEGF-A is crucial for angiogenesis in a prototypical model of carcinogenesis, whose loss is not readily compensated...
ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivoGieri Camenisch
Department of Molecular Oncology, Genentech, Inc, South San Francisco, California 94080, USA
J Biol Chem 277:17281-90. 2002..Taken together, our data demonstrate that ANGPTL3 is the first member of the angiopoietin-like family of secreted factors binding to integrin alpha(v)beta(3) and suggest a possible role in the regulation of angiogenesis...
Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cellsRui Lin
Department of Molecular Oncology, Genentech Inc, South San Francisco, California 94080, USA
J Biol Chem 277:8724-9. 2002....
Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitroJean Christophe Tille
Department of Cell Biology and Morphology, University Medical Center, Geneva, Switzerland
Exp Cell Res 285:286-98. 2003..Taken together, these findings point to the central role of VEGFR-2 in the angiogenic signaling pathways induced by VEGF-C(deltaNdeltaC) and VEGF-A...
Mouse endocrine gland-derived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesisJennifer LeCouter
Department of Molecular Oncology, Genentech Inc, South San Francisco, California 94080, USA
Endocrinology 144:2606-16. 2003..We propose that mouse EG-VEGF, like human EG-VEGF, plays a role in regulating the phenotype and growth properties of endothelial cells within distinct capillary beds...
Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovariesNapoleone Ferrara
Department of Molecular Oncology, Genentech Incorporated, South San Francisco, California 94080, USA
Am J Pathol 162:1881-93. 2003....
Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studiesHans Peter Gerber
Departments of Molecular Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Cancer Res 65:671-80. 2005..Finally, safety pharmacology studies with bevacizumab in cynomolgus monkeys showed that this agent is generally well tolerated with no unexpected adverse events...
Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilizationJennifer LeCouter
Department of Physiology, Genentech, Inc, South San Francisco, CA 94080, USA
Proc Natl Acad Sci U S A 101:16813-8. 2004..Bv8 potentially modulates growth, survival, and function of cells of the innate and adaptive immune systems, possibly through autocrine or paracrine signaling mechanisms...
Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesisNan Tang
Molecular Biology Section, Division of Biological Sciences, University of California, San Diego, San Diego, California 92093, USA
Cancer Cell 6:485-95. 2004..We thus show that a HIF-1alpha-driven, VEGF-mediated autocrine loop in EC is an essential component of solid tumor angiogenesis...
Angiogenesis-dependent and independent phases of intimal hyperplasiaRohit Khurana
Centre for Cardiovascular Biology and Medicine, Department of Medicine, University College, London, UK
Circulation 110:2436-43. 2004..CONCLUSIONS: Our findings indicate that adventitial angiogenesis stimulates intimal thickening but does not initiate it...
Neutralizing VEGF bioactivity with a soluble chimeric VEGF-receptor protein flt(1-3)IgG inhibits testosterone-stimulated prostate growth in castrated miceIngela Franck Lissbrant
Department of Medical Biosciences, Pathology, , Ume, Sweden
Prostate 58:57-65. 2004....
Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulationHeike E Daldrup-Link
Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California, San Francisco, California 94143-0628, USA
Microcirculation 11:387-96. 2004..MRI assays of microvascular status as performed here may be useful to clinically monitor responses to anti-angiogenesis drugs and to optimize the choice and timing of cytotoxic drug administration...
VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesisJianying Dong
Department of Molecular Oncology, Genentech Inc, South San Francisco, CA 94080, USA
EMBO J 23:2800-10. 2004..Thus, PDGFR alpha signaling is required for the recruitment of VEGF-producing stromal fibroblasts for tumor angiogenesis and growth. Our findings highlight a novel aspect of PDGFR alpha signaling in tumorigenesis...
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerHerbert Hurwitz
Duke University, Durham, NC, USA
N Engl J Med 350:2335-42. 2004..Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclinical and clinical activity against metastatic colorectal cancer, particularly in combination with chemotherapy...
VEGFA is necessary for chondrocyte survival during bone developmentElazar Zelzer
Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
Development 131:2161-71. 2004....
Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cellsBoris A Hesser
Department of Molecular Oncology, Genentech, South San Francisco, CA 94080, USA
Blood 104:149-58. 2004....
EG-VEGF and Bv8. a novel family of tissue-selective mediators of angiogenesis, endothelial phenotype, and functionJennifer LeCouter
Department of Molecular Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080, USA
Trends Cardiovasc Med 13:276-82. 2003..The potential advantage of tissue-specific angiogenic therapeutics may be the reduction of systemic side effects. Additionally, these peptides or their receptors may be attractive targets for inhibition in several disorders...
The hypoxic response of tumors is dependent on their microenvironmentBarbara Blouw
Molecular Biology Section, Division of Biological Sciences, University of California at San Diego, Pacific Hall Room 1212, MC-0366, 9500 Gilman Drive, La Jolla, CA 92093, USA
Cancer Cell 4:133-46. 2003..These results demonstrate that HIF-1alpha has differential roles in tumor progression, which are greatly dependent on the extant microenvironment of the tumor...
VEGF regulates remodeling during permanent anatomic closure of the ductus arteriosusRonald I Clyman
Cardiovascular Research Institute, University of California, San Francisco, California 94143-0544, USA
Am J Physiol Regul Integr Comp Physiol 282:R199-206. 2002..05) increase in vasa vasorum ingrowth and neointima formation. We conclude that VEGF plays an important role in the formation of neointimal mounds and vasa vasorum ingrowth during permanent ductus closure...
Research Grants
- Angiogenesis:Novel Basic Science Insight & Human TherapyNapoleone Ferrara; Fiscal Year: 2004..abstract_text> ..
